GoogleFunding and dealsPricing and access
Isomorphic Labs raises $5 billion Series C co-led by Greenoaks and Sequoia
Isomorphic Labs, the AI drug design company spun out of DeepMind, announced a $5 billion Series C round on Nov. 17.
Sources: Isomorphic Labs, TechCrunch
In this story
Isomorphic Labs, the AI drug design company spun out of DeepMind, announced a $5 billion Series C round on Nov. 17. Greenoaks and Sequoia Capital co-led the round, Andreessen Horowitz joined as a new investor, and Alphabet continued to invest. All existing investors took part, including Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund. The company said the money will go toward its drug design engine IsoDDE and the infrastructure to take its candidates into clinical trials. It reported positive preclinical results in oncology and immunology. The valuation was not disclosed. The previous round was a $2.1 billion Series B led by Thrive Capital in May 2026.
Sources
4 sources
- “Isomorphic Labs announces Series C investment round”The company’s Series C announcement and press release · isomorphiclabs.com
- “Isomorphic Labs announces $5 Billion Series C funding (basın bülteni, PDF)”Full press release: investors, use of proceeds, Hassabis and investor quotes · storage.googleapis.com
- “Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials”Valuation not disclosed; earlier Series B context · techcrunch.com
- “Isomorphic Labs announces Series B investment round”Previous round: $2.1 billion led by Thrive Capital · isomorphiclabs.com
About this story
- Written by
- Yiğit Kasap · JARRUS
- Story date
- On the site
- since Nov. 18, 2026
- @jarrus.tech posted this story on Nov. 18, 2026.
- Report an error
- Spotted an error in this story? [email protected] · Instagram